Search

Your search keyword '"Genge, Angela"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Genge, Angela" Remove constraint Author: "Genge, Angela" Publisher taylor & francis Remove constraint Publisher: taylor & francis
30 results on '"Genge, Angela"'

Search Results

1. Reliability and validity of speech & pause measures during passage reading in ALS

2. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

3. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

4. How to break the news in amyotrophic lateral sclerosis/motor neuron disease: practical guidelines from experts.

5. International network for ALS research and care (INARC).

6. Amyotrophic lateral sclerosis: exploring pathophysiology in the context of treatment.

7. The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.

8. Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian French.

9. Harmonized standard operating procedures for administering the ALS functional rating scale-revised.

10. COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.

11. Primary lateral sclerosis natural history study - planning, designing, and early enrollment.

12. Oral Edaravone - Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis.

13. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.

14. The future of ALS diagnosis and staging: where do we go from here?

15. CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS.

16. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.

17. Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.

18. Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices.

19. Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial.

20. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.

21. The NEALS primary lateral sclerosis registry.

22. Preface: promoting research in PLS: current knowledge and future challenges.

23. Reliability and validity of speech & pause measures during passage reading in ALS.

25. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.

27. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R.

28. Understanding the use of NIV in ALS: results of an international ALS specialist survey.

29. Respiratory measures in amyotrophic lateral sclerosis.

30. A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.

Catalog

Books, media, physical & digital resources